Silicon Bone Health Supplement Research Arrives at a Curious Impasse

The Oasis Health Journal · Submitted September 12, 2026 · 3:00 PM EDT

By June Mackerel · Edited by Colette Ward

Silicon accumulates in bone matrices. One can observe this under a microscope, measure it with sufficient patience, and publish papers about it in journals with terrifically long names. What remains unclear, in a way that is rather difficult to ignore once you notice it, is whether swallowing a silicon bone health supplement has anything whatsoever to do with the silicon that ends up in your bones, or whether the entire category represents an extended act of faith in the power of proximity.

The case for silicon rests on its presence. It is there, in bone tissue, in small but measurable amounts. Researchers have documented this in humans, in animals, in petri dishes, and in the kind of exhaustive review articles that cite eighty-three other papers and conclude that further research is needed. What they have not documented, with anything approaching the rigour one might hope for, is a controlled human trial in which people took a bioavailable silicon powder, had their bone density measured before and after, and the results were sufficiently impressive that anyone involved felt moved to publish them in a journal anyone reads.

What the Bone Research Actually Shows (Without Silicon)

A recent review examined microneedle-based transdermal delivery systems for metabolic bone diseases. Microneedles, for those fortunate enough not to have encountered them, are arrays of tiny needles designed to penetrate the outer layer of skin and deliver therapeutics directly into tissue, bypassing the gastrointestinal tract entirely, and also bypassing one's sense of having made sensible life choices. The review detailed how these systems have evolved into rather sophisticated platforms capable of targeting bone tissue with enzymes, hormones, and other substances that one's bone cells might theoretically find useful.

One notes the review did not mention silicon.

It mentioned a great many other things, including stimuli-responsive release mechanisms, immunomodulatory functions, and the manufacturing challenges of producing millions of identical tiny needles without anyone losing an eye, but silicon did not appear to have made the list. This is not necessarily damning. It does, however, suggest that when bone researchers convene to discuss the future of targeted skeletal therapeutics, silicon is not queuing at the front, or indeed anywhere visible from the front.

In a separate study, researchers treated ENPP1-deficient mice with bone-targeted enzyme replacement therapy. The mice had hearing loss caused by poor mineralisation of their auditory ossicles, the three tiny bones in the middle ear responsible for conducting sound. After seventeen weeks of treatment with a targeted enzyme called ENPP1-Fc, the mice showed improved hearing thresholds at multiple frequencies, restored matrix mineralisation in the malleus, and corrected osteocyte properties. The bone-targeted version of the enzyme worked better than the soluble version, which is exactly what one would predict if targeting matters, and also if the researchers had been paying attention the first time.

The mice were not given silicon. They were given an enzyme they lacked, delivered in a way that got it to the bones that needed it, and the bones improved in ways one could measure with equipment rather than hope. It is a rather elegant demonstration of what bone-targeted therapeutics look like when they work, and it leaves the question of silicon's role looking somewhat forlorn by comparison, like a guest who arrived at the wrong party and is too polite to leave.

Does Silicon Help Bone Strength (and How Would We Know)

The difficulty with bone density supplement silicon is not that it fails spectacularly. Spectacular failure would at least provide data. The difficulty is that it exists in a sort of evidential no-man's-land where its presence in bone tissue is treated as sufficient proof of its necessity, and the absence of compelling human intervention trials is met with the assurance that such trials are merely inconvenient, not impossible, and will surely arrive in due course, perhaps on the same train as the one carrying affordable housing and a functional healthcare system.

One might reasonably ask how much silicon one ought to take, supposing one were inclined to take it at all. The answer depends heavily on whom you ask. Supplement labels suggest doses ranging from ten to forty milligrams per day, which is a sufficiently wide range to inspire confidence in absolutely no one. Some brands market plant-based silicon for bone support, extracted from bamboo or horsetail, on the grounds that plants contain silicon in forms that are theoretically more bioavailable than the kind you might find in sand or windowpanes. Whether the human digestive system agrees with this assessment is another matter, and one it has so far declined to comment on.

A recent European Food Safety Authority review assessed fluoride exposure from all sources, including drinking water, food, salt, and the dental care products that children swallow despite instructions to the contrary. The review found that fluoride intake above certain thresholds was associated with adverse effects on the developing brain, thyroid function, and bone mineralisation. They established a safe level of intake for pregnant women at 3.3 milligrams per day, and tolerable upper intake levels for children ranging from one to two milligrams per day depending on age.

Fluoride, like silicon, accumulates in bone. The difference is that fluoride's effects, both beneficial and harmful, have been studied in sufficient detail that regulators felt able to set numerical limits with something approaching confidence. Silicon has not reached that threshold. It remains in the category of substances about which one can say a great many vaguely positive things without being required to demonstrate any of them, which is a pleasant category to be in if you are a supplement ingredient, and a less pleasant one if you are the person buying it.

Silicon Supplement vs Collagen for Bones (a Question Nobody Asked)

Marketing materials for silicon supplements occasionally suggest that silicon works alongside collagen to support bone structure, as though the two were colleagues in the same department, possibly sharing a kettle. Collagen is indeed a structural protein in bone, accounting for roughly ninety percent of the organic matrix, and its role is sufficiently well-established that no one bothers to argue about it any more. Silicon's role, by contrast, is the subject of speculation presented with unwarranted certainty.

One recent promotional document, which I shall not name because it does not deserve the attention, claimed that silicon is 'essential' for collagen synthesis. Essential is a technical term. It means that without the substance in question, a specific biological process cannot occur, and deficiency produces a recognisable syndrome. Silicon has not met that bar. It is present, it may be helpful, it might under certain circumstances contribute to something that matters, but essential it is not, and the distinction is not a small one, however much the copywriter would prefer it were.

If you are deciding between a silicon collagen support product and something with an actual evidence base, I am afraid the choice is less difficult than the packaging suggests. Collagen supplementation has at least been studied in humans. The results are mixed, the effect sizes are modest, and the mechanisms remain debated, but the studies exist. Silicon supplementation for bone health in humans remains the kind of research project that sounds plausible in a grant application and has not yet troubled the pages of a major medical journal, or indeed the pages of a minor one.

The Best Silicon Supplement for Bone Health (Remains Hypothetical)

Determining the best silicon supplement for bone health would require knowing whether any silicon supplement does anything for bone health, which would in turn require a properly controlled trial with a reasonable sample size, a meaningful duration, and outcomes measured with something other than optimism and a nicely designed label. We do not have that trial. We have silicon's presence in bone, its theoretical involvement in mineralisation, and a great deal of marketing language that treats the gap between those two facts as though it were not there, like a suspension bridge with no cables.

The silicon bioavailability bone matrix question is real. Different forms of silicon are absorbed differently, and orthosilicic acid is generally considered more bioavailable than other forms, but bioavailability only matters if there is something worth delivering. A highly bioavailable placebo remains a placebo, merely one that arrives more efficiently, like a parcel that contains nothing but arrives on time.

One is left with the impression that silicon supplementation for bones occupies the same category as a great many other supplement interventions: not actively harmful, not wholly implausible, and not backed by the kind of evidence that would survive contact with a sceptical clinician or a moderately alert undergraduate. If you are taking it, you are participating in an uncontrolled experiment with a sample size of one. If it makes you feel better, that is not nothing, but it is also not data, and the difference matters rather more than the wellness industry would prefer you to notice.

The bone-targeted enzyme therapy in those ENPP1-deficient mice worked because it delivered a missing enzyme to the tissue that needed it, in a form that could do something useful once it arrived. That is what targeted skeletal therapeutics look like when the mechanism is understood and the delivery is optimised. Silicon supplementation, by contrast, is what it looks like when we observe that a substance is present in a tissue and conclude, without further ceremony, that more of it must be better. One of these approaches has produced measurable improvements in bone properties and hearing thresholds in a controlled study. The other has produced a shelf full of bone health supplements with rather confident labels and no particular obligation to prove anything.

I am not suggesting silicon has no role in bone health. I am suggesting that if it does, we have not yet done the work to find out what that role is, and selling it as though we had is a bit much, even by the standards of an industry that considers 'supports normal function' a meaningful claim.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Microneedle-based transdermal delivery systems for metabolic bone diseases: advances, challenges, and future perspectives, Frontiers in bioengineering and biotechnology (2026).
2. Improvements in hearing loss with bone-targeted enzyme replacement therapy are associated with corrected hypomineralization and osteocyte properties of auditory ossicles in Enpp1-deficient mice, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2025).
3. Updated consumer risk assessment of fluoride in food and drinking water including the contribution from other sources of oral exposure, EFSA journal. European Food Safety Authority (2025).